Skip to main content
Log in

TAVI with SAPIEN 3 cost effective vs surgery for aortic stenosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Tarride J-E, et al. A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients. ClinicoEconomics and Outcomes Research 11: 477-486, 29 Jul 2019. Available from: URL: https://doi.org/10.2147/CEOR.S208107

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

TAVI with SAPIEN 3 cost effective vs surgery for aortic stenosis. PharmacoEcon Outcomes News 834, 34 (2019). https://doi.org/10.1007/s40274-019-6134-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6134-9

Navigation